Hence : Actualité Hence en direct - P1 | Bourse Reflex
Accueil > Tags > Hence

  • Toutes les actualités en rapport avec « Hence »

15/11 07:30 Hence - Quantum Genomics announces recruitment of first patients in the NEW-HOPE arterial hypertension study in the United States

13/10 17:20 Hence - Artprice analyzes the FIAC's strategy (44th edition) in its competition with Frieze... and public sales.

02/10 17:15 Hence - Artprice: Contemporary Art Market Annual Report: + 1,370% in 16 years, generating an average annual return of 5.6%

22/09 18:50 Hence - 1st Half Year 2016 Results

17/05 14:25 Hence - Negative interest rates have increased investment in the Art Market.

10/05 14:30 Hence - BPI-labelled Artprice announces its Blockchain project for the Art Market.

05/05 10:10 Hence - PLANNED SHARE CAPITAL INCREASE OF APPROXIMATELY EUR 52,000,000 SUPPORTED BY THE SHAREHOLDERS ICMI AND PATHÉ AND GUARANTEED BY NATIXIS

01/04 07:00 Hence - After a successful financial restructuring, THEOLIA focuses on its development

27/03 07:00 Hence - 2014 results: Significant improvement of the operational performance in a year of adverse market dynamics

10/10 11:10 Hence - Second part of an exclusive interview with Thierry Ehrmann, CEO of Artprice.com (9 October 2011)

23/09 07:00 Hence - Eurofins announces the inauguration of its Nantes laboratory extension turning it into the largest single-site independent food testing laboratory in the world

30/08 07:30 Hence - Strong Growth and Operating Leverage Trebles Eurofins' Net Profit in H1 2011

24/06 08:30 Hence - ALTAREA ELIGIBLE FOR DSS LONG ONLY FROM JUNE 27th 2011

10/02 09:44 Hence - RÉSULTATS PRÉLIMINAIRES POUR L'EXERCICE 2010 : CHIFFRE D'AFFAIRES DE 728,1 MILLIONS D'EUROS, BÉNÉFICE NET DE 108,6 MILLIONS D'EUROS. LA RENTABILITÉ DE 2009 EST MAINTENUE

26/10 17:31 Hence - RESULTATS POSITIFS LES NEUF PREMIERS MOIS DE L'ANNEE 2010, EBIT ET RESULTAT NET EN HAUSSE

28/07 15:02 Hence - RESULTATS POSITIFS AU PREMIER SEMESTRE 2010, HAUSSE DE L'EBIT ET DU RESULTAT NET

15/07 13:53 Hence - LA PROCEDURE DECENTRALISÉE POUR L'AUTORISATION DE MISE SUR LE MARCHE DE PITAVASTATIN (LIVAZO®) EN EUROPE A ABOUTI

09/06 10:15 Hence - RECORDATI S'IMPLANTE SUR LE MARCHÉ ROUMAIN

07/05 12:06 Hence - RECORDATI SIGNE AVEC ZAMBON UN ACCORD DE COMMERCIALISATION CONJOINTE DE LA SILODOSINE EN FRANCE

13/04 17:11 Hence - LES ACTIONNAIRES APPROUVENT LES BILANS DE L'EXERCICE 2009. DIVIDENDE PAR ACTION 0,275 euro (+ 10 %).